: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Influenza

Free Subscription

Articles published in J Virol
Retrieve available abstracts of 342 articles:
HTML format

Single Articles

September 2023

WALLACE LE, de Vries E, van Kuppeveld FJM, de Haan CAM, et al
Neuraminidase-dependent entry of influenza A virus is determined by hemagglutinin receptor-binding specificity.
J Virol. 2023 Sep 27:e0060223. doi: 10.1128/jvi.00602.
PubMed Abstract available

August 2023

LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
PubMed Abstract available

JIN H, Cheng L, Gong Y, Zhu Y, et al
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
PubMed Abstract available

ZHANG W, Shi K, Geng Q, Herbst M, et al
Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
PubMed Abstract available

LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
PubMed Abstract available

MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851.
PubMed Abstract available

THOMPSON D, Cismaru CV, Rougier JS, Schwemmle M, et al
The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins.
J Virol. 2023 Aug 4:e0038823. doi: 10.1128/jvi.00388.
PubMed Abstract available

July 2023

TALUKDAR SN, McGregor B, Osan JK, Hur J, et al
Respiratory Syncytial Virus Infection Does Not Induce Epithelial-Mesenchymal Transition.
J Virol. 2023;97:e0039423.
PubMed Abstract available

HICKERSON BT, Petrovskaya SN, Dickensheets H, Donnelly RP, et al
Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
J Virol. 2023 Jul 5:e0015423. doi: 10.1128/jvi.00154.
PubMed Abstract available

JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
PubMed Abstract available

June 2023

HUANG J, Chen Z, Ye Y, Shao Y, et al
DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.
J Virol. 2023;97:e0068723.
PubMed Abstract available

YANG X, Duan H, Liu X, Zhang X, et al
Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610.
PubMed Abstract available

TERASAKI K, Narayanan K, Makino S
Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659.
PubMed Abstract available

LI A, Zhang B, Zhao K, Yin Z, et al
SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512.
PubMed Abstract available

GOFFIN E, Du X, Hemmi S, Machiels B, et al
A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
PubMed Abstract available

CHEN P, Jin Z, Peng L, Zheng Z, et al
Characterization of an Emergent Chicken H3N8 Influenza Virus in Southern China: a Potential Threat to Public Health.
J Virol. 2023 Jun 8:e0043423. doi: 10.1128/jvi.00434.
PubMed Abstract available

ZHENG H, Ma L, Gui R, Lin X, et al
Correction for Zheng et al., "G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2".
J Virol. 2023 Jun 6:e0054623. doi: 10.1128/jvi.00546.
PubMed

May 2023

WANG C, Honce R, Salvatore M, Chow D, et al
Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice.
J Virol. 2023 May 31:e0049323. doi: 10.1128/jvi.00493.
PubMed Abstract available

RUNSTADLER JA, Lowen AC, Kayali G, Tompkins SM, et al
Field Research Is Essential to Counter Virological Threats.
J Virol. 2023;97:e0054423.
PubMed Abstract available

REZENDE W, Ye X, Angelo LS, Carisey AF, et al
The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent.
J Virol. 2023;97:e0025423.
PubMed Abstract available

SREENIVASAN CC, Liu R, Gao R, Guo Y, et al
Influenza C and D Viruses Demonstrated a Differential Respiratory Tissue Tropism in a Comparative Pathogenesis Study in Guinea Pigs.
J Virol. 2023 May 18:e0035623. doi: 10.1128/jvi.00356.
PubMed Abstract available

JIANG H, Joshi A, Gan T, Janowski AB, et al
The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635.
PubMed Abstract available

SLANINA H, Madhugiri R, Wenk K, Reinke T, et al
Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465.
PubMed Abstract available

ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286.
PubMed Abstract available

ZHANG L, Wang Y, Shao Y, Guo J, et al
Fine Regulation of Influenza Virus RNA Transcription and Replication by Stoichiometric Changes in Viral NS1 and NS2 Proteins.
J Virol. 2023 May 11:e0033723. doi: 10.1128/jvi.00337.
PubMed Abstract available

SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al
Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992.
PubMed Abstract available

April 2023

SPECK P, Mackenzie J, Bull RA, Slobedman B, et al
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451.
PubMed

PEACOCK TP, Sheppard CM, Lister MG, Staller E, et al
Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus.
J Virol. 2023 Apr 19:e0021323. doi: 10.1128/jvi.00213.
PubMed Abstract available

KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al
SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144.
PubMed Abstract available

LIN SJ, Lin KM, Chen SJ, Ku CC, et al
Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression.
J Virol. 2023 Apr 6:e0010223. doi: 10.1128/jvi.00102.
PubMed Abstract available

March 2023

TAN Y, Shilts MH, Rosas-Salazar C, Puri V, et al
Influence of Sex on Respiratory Syncytial Virus Genotype Infection Frequency and Nasopharyngeal Microbiome.
J Virol. 2023;97:e0147222.
PubMed Abstract available

ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al
A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365.
PubMed Abstract available

WANG X, Wang W, Wang T, Wang J, et al
SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011.
PubMed Abstract available

MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al
Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host.
J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099.
PubMed Abstract available

February 2023

FROLOV I, Agback T, Palchevska O, Dominguez F, et al
All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865.
PubMed Abstract available

ZHANG L, Hom N, Ojha A, Lovendahl KN, et al
Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions.
J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650.
PubMed Abstract available

CHIEN YA, Alford BK, Wasik BR, Weichert WS, et al
Single Particle Analysis of H3N2 Influenza Entry Differentiates the Impact of the Sialic Acids (Neu5Ac and Neu5Gc) on Virus Binding and Membrane Fusion.
J Virol. 2023 Feb 13:e0146322. doi: 10.1128/jvi.01463.
PubMed Abstract available

WANG X, Wen Z, Cao H, Luo J, et al
Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611.
PubMed Abstract available

WANG Y, Ge F, Wang J, Li H, et al
Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
J Virol. 2023 Feb 13:e0176422. doi: 10.1128/jvi.01764.
PubMed Abstract available

AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
PubMed Abstract available

WAN Z, Zhao Z, Sang J, Jiang W, et al
Amino Acid Variation at Hemagglutinin Position 193 Impacts the Properties of H9N2 Avian Influenza Virus.
J Virol. 2023 Feb 7:e0137922. doi: 10.1128/jvi.01379.
PubMed Abstract available

BEI C, Zhang C, Wu H, Feng H, et al
DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus Replication via Stabilization of the Phosphoprotein.
J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035.
PubMed Abstract available

SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532.
PubMed Abstract available

January 2023

TJARNHAGE E, Brown D, Bogen B, Andersen TK, et al
Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza.
J Virol. 2023 Jan 31:e0169422. doi: 10.1128/jvi.01694.
PubMed Abstract available

GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al
Virology under the Microscope-a Call for Rational Discourse.
J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089.
PubMed Abstract available

GAUDINO M, Lion A, Sagne E, Nagamine B, et al
The Activation of the RIG-I/MDA5 Signaling Pathway upon Influenza D Virus Infection Impairs the Pulmonary Proinflammatory Response Triggered by Mycoplasma bovis Superinfection.
J Virol. 2023 Jan 24:e0142322. doi: 10.1128/jvi.01423.
PubMed Abstract available

LIU MQ, Lin HF, Li J, Chen Y, et al
A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719.
PubMed Abstract available

RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al
Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478.
PubMed Abstract available

MA J, Liu X, Zhou M, Chen P, et al
A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684.
PubMed Abstract available

SHIWA-SUDO N, Sakai Y, Iwata-Yoshikawa N, Watanabe S, et al
Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
J Virol. 2023 Jan 12:e0136622. doi: 10.1128/jvi.01366.
PubMed Abstract available

CREAGER HM, Kieran TJ, Zeng H, Sun X, et al
Utility of Human In Vitro Data in Risk Assessments of Influenza A Virus Using the Ferret Model.
J Virol. 2023 Jan 5:e0153622. doi: 10.1128/jvi.01536.
PubMed Abstract available

MCGINNES CULLEN L, Luo B, Wen Z, Zhang L, et al
The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.
J Virol. 2023 Jan 5:e0190022. doi: 10.1128/jvi.01900.
PubMed Abstract available

December 2022

CHANG P, Lukosaityte D, Sealy JE, Rijal P, et al
Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
J Virol. 2022 Dec 21:e0143122. doi: 10.1128/jvi.01431.
PubMed Abstract available

GOUMA S, Furey C, Santos JJS, Parkhouse K, et al
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
J Virol. 2022 Dec 19:e0172322. doi: 10.1128/jvi.01723.
PubMed Abstract available

MEADE P, Strohmeier S, Bermudez-Gonzalez MC, Garcia-Sastre A, et al
Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity.
J Virol. 2022 Dec 19:e0107022. doi: 10.1128/jvi.01070.
PubMed Abstract available

CHEN LF, Xu WB, Xiong S, Cai JX, et al
PIK-24 Inhibits RSV-Induced Syncytium Formation via Direct Interaction with the p85alpha Subunit of PI3K.
J Virol. 2022;96:e0145322.
PubMed Abstract available

VALIENTE L, Lopez-Arguello S, Rodriguez-Huete A, Valbuena A, et al
Molecular Determinants of Human Rhinovirus Infection, Assembly, and Conformational Stability at Capsid Protein Interfaces.
J Virol. 2022;96:e0084022.
PubMed Abstract available

CHEN Y, Wu Y, Chen S, Zhan Q, et al
Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
J Virol. 2022 Dec 5:e0124522. doi: 10.1128/jvi.01245.
PubMed Abstract available

November 2022

BELSER JA, Sun X, Kieran TJ, Brock N, et al
Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
J Virol. 2022 Nov 30:e0140322. doi: 10.1128/jvi.01403.
PubMed Abstract available

CHOI SSA, Chan HH, Chan CM, Wang X, et al
Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry.
J Virol. 2022 Nov 30:e0141822. doi: 10.1128/jvi.01418.
PubMed Abstract available

LI J, Xue L, Wang J, Meng A, et al
Activation of the Chemokine Receptor CCR1 and Preferential Recruitment of Galphai Suppress RSV Replication: Implications for Developing Novel Respiratory Syncytial Virus Treatment Strategies.
J Virol. 2022;96:e0130922.
PubMed Abstract available

STEPHENS LM, Ross KA, McLellan JS, Narasimhan B, et al
Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model.
J Virol. 2022;96:e0150222.
PubMed Abstract available

LISTA MJ, Winstone H, Wilson HD, Dyer A, et al
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
J Virol. 2022 Nov 9:e0125022. doi: 10.1128/jvi.01250.
PubMed Abstract available

JAMES J, Bhat S, Walsh SK, Karunarathna TK, et al
The Origin of Internal Genes Contributes to the Replication and Transmission Fitness of H7N9 Avian Influenza Virus.
J Virol. 2022 Nov 7:e0129022. doi: 10.1128/jvi.01290.
PubMed Abstract available

WANG X, Kerkmann L, Hetzel M, Windmann S, et al
Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
J Virol. 2022 Nov 7:e0113322. doi: 10.1128/jvi.01133.
PubMed Abstract available

CZERKIES M, Kochanczyk M, Korwek Z, Prus W, et al
Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
J Virol. 2022 Nov 3:e0134122. doi: 10.1128/jvi.01341.
PubMed Abstract available

MO JS, Abente EJ, Cardenas Perez M, Sutton TC, et al
Transmission of Human Influenza A Virus in Pigs Selects for Adaptive Mutations on the HA Gene.
J Virol. 2022 Nov 1:e0148022. doi: 10.1128/jvi.01480.
PubMed Abstract available

October 2022

SACCO MT, Bland KM, Horner SM
WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
PubMed Abstract available

GUO K, Yombo DJK, Schmit T, Wang Z, et al
Cellular Heterogeneity and Molecular Reprogramming of the Host Response during Influenza Acute Lung Injury.
J Virol. 2022 Oct 26:e0124622. doi: 10.1128/jvi.01246.
PubMed Abstract available

PENN R, Tregoning JS, Flight KE, Baillon L, et al
Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model.
J Virol. 2022 Oct 13:e0117822. doi: 10.1128/jvi.01178.
PubMed Abstract available

VAN ROYEN T, Sedeyn K, Moschonas GD, Toussaint W, et al
An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.
J Virol. 2022;96:e0129722.
PubMed Abstract available

TAN TS, Toyoda M, Ode H, Barabona G, et al
Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike.
J Virol. 2022 Oct 10:e0116222. doi: 10.1128/jvi.01162.
PubMed Abstract available

BONIFACIO JPPL, Williams N, Garnier L, Hugues S, et al
Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups.
J Virol. 2022 Oct 3:e0087122. doi: 10.1128/jvi.00871.
PubMed Abstract available

September 2022

CHEN M, Wang MH, Shen XG, Liu H, et al
Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner.
J Virol. 2022 Sep 29:e0131822. doi: 10.1128/jvi.01318.
PubMed Abstract available

BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
Correction for Bimler et al., "Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A".
J Virol. 2022 Sep 27:e0135822. doi: 10.1128/jvi.01358.
PubMed

GUAN M, Olivier AK, Lu X, Epperson W, et al
The Sialyl Lewis X Glycan Receptor Facilitates Infection of Subtype H7 Avian Influenza A Viruses.
J Virol. 2022 Sep 20:e0134422. doi: 10.1128/jvi.01344.
PubMed Abstract available

GELLENONCOURT S, Saunders N, Robinot R, Auguste L, et al
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
J Virol. 2022 Sep 19:e0130122. doi: 10.1128/jvi.01301.
PubMed Abstract available

SIA ZR, Chiem K, Huang WC, Seffouh A, et al
Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.
J Virol. 2022 Sep 15:e0100622. doi: 10.1128/jvi.01006.
PubMed Abstract available

CALIENDO V, Leijten L, van de Bildt MWG, Poen MJ, et al
Long-Term Protective Effect of Serial Infections with H5N8 Highly Pathogenic Avian Influenza Virus in Wild Ducks.
J Virol. 2022 Sep 13:e0123322. doi: 10.1128/jvi.01233.
PubMed Abstract available

BEDI S, Mudgal R, Haag A, Ono A, et al
A Glu-Glu-Tyr Sequence in the Cytoplasmic Tail of the M2 Protein Renders Influenza A Virus Susceptible to Restriction of the Hemagglutinin-M2 Association in Primary Human Macrophages.
J Virol. 2022 Sep 13:e0071622. doi: 10.1128/jvi.00716.
PubMed Abstract available

AO Z, Ouyang MJ, Olukitibi TA, Warner B, et al
A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
J Virol. 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
PubMed Abstract available

EVSEEV D, Miranzo-Navarro D, Fleming-Canepa X, Webster RG, et al
Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.
J Virol. 2022 Sep 7:e0077622. doi: 10.1128/jvi.00776.
PubMed Abstract available

August 2022

ZHANG C, Cui H, Guo Z, Chen Z, et al
SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters.
J Virol. 2022 Aug 30:e0103422. doi: 10.1128/jvi.01034.
PubMed Abstract available

SHEN W, Wang Q, Wang Z, Liu M, et al
Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
J Virol. 2022 Aug 29:e0123822. doi: 10.1128/jvi.01238.
PubMed Abstract available

FAN B, Peng Q, Song S, Shi D, et al
Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.
J Virol. 2022 Aug 29:e0102422. doi: 10.1128/jvi.01024.
PubMed Abstract available

MARTINS M, do Nascimento GM, Nooruzzaman M, Yuan F, et al
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
J Virol. 2022 Aug 24:e0096122. doi: 10.1128/jvi.00961.
PubMed Abstract available

SU C, He J, Han P, Bai B, et al
Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
J Virol. 2022 Aug 24:e0081422. doi: 10.1128/jvi.00814.
PubMed Abstract available

KAZEMI S, Lopez-Munoz AD, Holly J, Jin L, et al
Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
J Virol. 2022 Aug 24:e0025622. doi: 10.1128/jvi.00256.
PubMed Abstract available

JIAO Z, Yan Y, Chen Y, Wang G, et al
Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
PubMed Abstract available

NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
PubMed Abstract available

BLAUROCK C, Pfaff F, Scheibner D, Hoffmann B, et al
Evidence for Different Virulence Determinants and Host Response after Infection of Turkeys and Chickens with Highly Pathogenic H7N1 Avian Influenza Virus.
J Virol. 2022 Aug 22:e0099422. doi: 10.1128/jvi.00994.
PubMed Abstract available

ZHOU Y, Zheng R, Liu D, Liu S, et al
UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
J Virol. 2022 Aug 18:e0074122. doi: 10.1128/jvi.00741.
PubMed Abstract available

GUPTA SL, Mantus G, Manning KE, Ellis M, et al
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
PubMed Abstract available

HAN Y, Bai X, Liu S, Zhu J, et al
XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
J Virol. 2022 Aug 16:e0077422. doi: 10.1128/jvi.00774.
PubMed Abstract available

SHI J, Zheng J, Tai W, Verma AK, et al
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
PubMed Abstract available

FARRUKEE R, Gunalan V, Maurer-Stroh S, Reading PC, et al
Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
J Virol. 2022;96:e0091822.
PubMed Abstract available

UNDI RB, Larabee JL, Filiberti A, Ulahannan S, et al
Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
J Virol. 2022 Aug 9:e0096722. doi: 10.1128/jvi.00967.
PubMed Abstract available

CHAN M, Tiwary M, Wu HL, Tailor N, et al
Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques.
J Virol. 2022 Aug 4:e0072822. doi: 10.1128/jvi.00728.
PubMed Abstract available

ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al
A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.
PubMed Abstract available

ZHAN W, Tian X, Zhang X, Xing S, et al
Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.
PubMed Abstract available

ABBADI N, Nagashima K, Pena-Briseno A, Ross TM, et al
Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
J Virol. 2022 Aug 2:e0089622. doi: 10.1128/jvi.00896.
PubMed Abstract available

SCHWAB LSU, Londrigan SL, Brooks AG, Hurt AC, et al
Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets.
J Virol. 2022 Aug 2:e0055922. doi: 10.1128/jvi.00559.
PubMed Abstract available

XU C, Zhang N, Yang Y, Liang W, et al
Immune Escape Adaptive Mutations in Hemagglutinin Are Responsible for the Antigenic Drift of Eurasian Avian-Like H1N1 Swine Influenza Viruses.
J Virol. 2022 Aug 2:e0097122. doi: 10.1128/jvi.00971.
PubMed Abstract available

LI Z, Fang P, Duan P, Chen J, et al
Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.
J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.
PubMed Abstract available

YUAN M, Chen X, Zhu Y, Dong X, et al
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
PubMed Abstract available

July 2022

FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
PubMed Abstract available

HUI X, Cao L, Xu T, Zhao L, et al
PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication.
J Virol. 2022 Jul 21:e0078622. doi: 10.1128/jvi.00786.
PubMed Abstract available

AKAISHI T, Horii A, Ishii T
Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.
PubMed

GUO H, Li A, Lin HF, Liu MQ, et al
The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
PubMed Abstract available

KAMIKI H, Murakami S, Nishikaze T, Hiono T, et al
Influenza A Virus Agnostic Receptor Tropism Revealed Using a Novel Biological System with Terminal Sialic Acid Knockout Cells.
J Virol. 2022 Jul 18:e0041622. doi: 10.1128/jvi.00416.
PubMed Abstract available

BEACH SS, Hull MA, Ytreberg FM, Patel JS, et al
Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein.
J Virol. 2022;96:e0035322.
PubMed Abstract available

MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
PubMed Abstract available

CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
PubMed Abstract available

OISHI K, Horiuchi S, Minkoff JM, tenOever BR, et al
The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
J Virol. 2022 Jul 12:e0076522. doi: 10.1128/jvi.00765.
PubMed Abstract available

PUSNIK J, Konig J, Mai K, Richter E, et al
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
PubMed Abstract available

VAN DE VEN K, van Dijken H, Du W, de Heij F, et al
Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route.
J Virol. 2022 Jul 11:e0073222. doi: 10.1128/jvi.00732.
PubMed Abstract available

YOUK S, Leyson C, Killian ML, Torchetti MK, et al
Evolution of the North American Lineage H7 Avian Influenza Viruses in Association with H7 Virus's Introduction to Poultry.
J Virol. 2022 Jul 7:e0027822. doi: 10.1128/jvi.00278.
PubMed Abstract available

HAMELE CE, Russell AB, Heaton NS
In Vivo Profiling of Individual Multiciliated Cells during Acute Influenza A Virus Infection.
J Virol. 2022 Jul 6:e0050522. doi: 10.1128/jvi.00505.
PubMed Abstract available

June 2022

VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.
PubMed

JIANG C, Li L, Xue M, Zhao L, et al
Long-Term Expanding Porcine Airway Organoids Provide Insights into the Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.
J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.
PubMed Abstract available

DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al
Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.
PubMed Abstract available

BI W, Chen G, Dang B
Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
PubMed Abstract available

CHAN CE, Ng CG, Lim AP, Seah SL, et al
The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
PubMed Abstract available

LIN J, Law R, Korosec CS, Zhou C, et al
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
PubMed Abstract available

SUN C, Yuan RY, Xie C, Sun JF, et al
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
PubMed Abstract available

LAVIE M, Dubuisson J, Belouzard S
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
PubMed Abstract available

CHRISTENSEN SR, Martin ET, Petrie JG, Monto AS, et al
The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade.
J Virol. 2022;96:e0220021.
PubMed Abstract available

SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
PubMed Abstract available

SCHEIBNER D, Breithaupt A, Luttermann C, Blaurock C, et al
Genetic Determinants for Virulence and Transmission of the Panzootic Avian Influenza Virus H5N8 Clade 2.3.4.4 in Pekin Ducks.
J Virol. 2022 Jun 7:e0014922. doi: 10.1128/jvi.00149.
PubMed Abstract available

CHEN X, Li J, Yang L, Zhou Y, et al
Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
PubMed Abstract available

LIU H, Bai Y, Zhang X, Gao T, et al
SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
PubMed Abstract available

May 2022

PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
J Virol. 2022 May 31:e0032022. doi: 10.1128/jvi.00320.
PubMed Abstract available

ZHENG H, Ma L, Gui R, Lin X, et al
G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2.
J Virol. 2022 May 23:e0049422. doi: 10.1128/jvi.00494.
PubMed Abstract available

VANDOORN E, Stadejek W, Parys A, Chepkwony S, et al
Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
J Virol. 2022 May 12:e0051922. doi: 10.1128/jvi.00519.
PubMed Abstract available

NCHIOUA R, Schundner A, Kmiec D, Prelli Bozzo C, et al
SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
J Virol. 2022 May 11:e0059422. doi: 10.1128/jvi.00594.
PubMed Abstract available

April 2022

DIEFENBACHER M, Tan TJC, Bauer DLV, Stadtmueller BM, et al
Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression.
J Virol. 2022 Apr 25:e0020522. doi: 10.1128/jvi.00205.
PubMed Abstract available

ROACH SN, Fiege JK, Shepherd FK, Wiggen TD, et al
Respiratory Influenza Virus Infection Causes Dynamic Tuft Cell and Innate Lymphoid Cell Changes in the Small Intestine.
J Virol. 2022 Apr 21:e0035222. doi: 10.1128/jvi.00352.
PubMed Abstract available

KIRKPATRICK ROUBIDOUX E, Sano K, McMahon M, Carreno JM, et al
Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
J Virol. 2022 Apr 21:e0033222. doi: 10.1128/jvi.00332.
PubMed Abstract available

ZHENG XS, Wang Q, Min J, Shen XR, et al
Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
PubMed Abstract available

RAJAN A, Piedra FA, Aideyan L, McBride T, et al
Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection.
J Virol. 2022;96:e0190421.
PubMed Abstract available

NUNEZ CASTREJON AM, O'Rourke SM, Kauvar LM, DuBois RM, et al
Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens.
J Virol. 2022;96:e0220121.
PubMed Abstract available

DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
PubMed Abstract available

BAO D, Lu C, Ma T, Xu G, et al
Hydrophobic Residues at the Intracellular Domain of the M2 Protein Play an Important Role in Budding and Membrane Integrity of Influenza Virus.
J Virol. 2022 Apr 11:e0037322. doi: 10.1128/jvi.00373.
PubMed Abstract available

CHEN J, Li Z, Guo J, Xu S, et al
SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
J Virol. 2022 Apr 7:e0003722. doi: 10.1128/jvi.00037.
PubMed Abstract available

FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
PubMed Abstract available

LI J, Lin C, Zhou X, Zhong F, et al
Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
J Virol. 2022 Apr 7:e0201321. doi: 10.1128/jvi.02013.
PubMed Abstract available

KLASSE PJ, Moore JP
Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
PubMed Abstract available

LIU X, Zheng L, Wang T, Li Y, et al
A System Based on Novel Parainfluenza Virus PIV5-L for Efficient Gene Delivery of B-Lymphoma Cells.
J Virol. 2022 Apr 4:e0025722. doi: 10.1128/jvi.00257.
PubMed Abstract available

March 2022

HANCOCK TJ, Hickman P, Kazerooni N, Kennedy M, et al
Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
J Virol. 2022 Mar 30:e0025022. doi: 10.1128/jvi.00250.
PubMed Abstract available

ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
J Virol. 2022 Mar 28:e0012822. doi: 10.1128/jvi.00128.
PubMed Abstract available

GENG Q, Shi K, Ye G, Zhang W, et al
Structural Basis for Human Receptor Recognition by SARS-CoV Omicron Variant BA.1.
J Virol. 2022 Mar 28:e0024922. doi: 10.1128/jvi.00249.
PubMed Abstract available

LIU MQ, Jiang RD, Guo J, Chen Y, et al
Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
PubMed Abstract available

XIANG J, Lu M, Shi M, Cheng X, et al
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
PubMed Abstract available

JIANG L, Samant N, Liu P, Somasundaran M, et al
Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
J Virol. 2022;96:e0198221.
PubMed Abstract available

LI Y, Liu S, Chen Y, Chen B, et al
Syk Facilitates Influenza A Virus Replication by Restraining Innate Immunity at the Late Stage of Viral Infection.
J Virol. 2022 Mar 16:e0020022. doi: 10.1128/jvi.00200.
PubMed Abstract available

BERKHOUT B, Herrera-Carrillo E
SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
J Virol. 2022 Mar 16:e0009022. doi: 10.1128/jvi.00090.
PubMed Abstract available

GAO J, Tang YD, Hu W, Zheng C, et al
When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
J Virol. 2022 Mar 16:e0013622. doi: 10.1128/jvi.00136.
PubMed Abstract available

ALLEN JD, Ross TM
Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
J Virol. 2022 Mar 15:e0165221. doi: 10.1128/jvi.01652.
PubMed Abstract available

METZ-ZUMARAN C, Kee C, Doldan P, Guo C, et al
Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
J Virol. 2022 Mar 9:e0170521. doi: 10.1128/jvi.01705.
PubMed Abstract available

HU M, Jones JC, Banoth B, Ojha CR, et al
Swine H1N1 Influenza Virus Variants with Enhanced Polymerase Activity and HA Stability Promote Airborne Transmission in Ferrets.
J Virol. 2022 Mar 7:e0010022. doi: 10.1128/jvi.00100.
PubMed Abstract available

February 2022

JUNG C, Kmiec D, Koepke L, Zech F, et al
Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?
J Virol. 2022 Feb 28:jvi0207721. doi: 10.1128/jvi.02077.
PubMed Abstract available

KIM EH, Nguyen TQ, Casel MAB, Rollon R, et al
Coinfection of SARS-CoV-2 and Influenza A virus increased disease severity, impaired neutralizing antibody, and CD4+ T cell responses.
J Virol. 2022 Feb 2:jvi0187321. doi: 10.1128/jvi.01873.
PubMed Abstract available

ROSU ME, Kok A, Bestebroer TM, de Meulder D, et al
Contribution of neuraminidase to the efficacy of seasonal split influenza vaccines in the ferret model.
J Virol. 2022 Feb 2:jvi0195921. doi: 10.1128/jvi.01959.
PubMed Abstract available

ARIUMI Y
Host cellular RNA helicases regulate SARS-CoV-2 infection.
J Virol. 2022 Feb 2:jvi0000222. doi: 10.1128/jvi.00002.
PubMed Abstract available

January 2022

MURER L, Petkidis A, Vallet T, Vignuzzi M, et al
Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
J Virol. 2022;96:e0106021.
PubMed Abstract available

LIU S, Chou CK, Wu WW, Luan B, et al
Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
J Virol. 2022 Jan 26:jvi0221621. doi: 10.1128/jvi.02216.
PubMed Abstract available

WONG TY, Horspool AM, Russ BP, Ye C, et al
Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice.
J Virol. 2022 Jan 26:jvi0218421. doi: 10.1128/jvi.02184.
PubMed Abstract available

SPRUIT CM, Zhu X, Tomris I, Carrasco MR, et al
N-glycolylneuraminic acid binding of avian and equine H7 influenza A viruses.
J Virol. 2022 Jan 19:jvi0212021. doi: 10.1128/jvi.02120.
PubMed Abstract available

BANERJEE S, De A, Kedia N, Bhakta K, et al
The species-specific 282 residue in the PB2 subunit of the polymerase regulates RNA synthesis and replication of influenza A viruses infecting bat and non-bat hosts.
J Virol. 2022 Jan 19:jvi0219021. doi: 10.1128/jvi.02190.
PubMed Abstract available

MIYAMOTO S, Muramoto Y, Shindo K, Fujita-Fujiharu Y, et al
Contribution of RNA-RNA interactions mediated by the genome packaging signals for the selective genome packaging of influenza A virus.
J Virol. 2022 Jan 19:JVI0164121. doi: 10.1128/JVI.01641.
PubMed Abstract available

DU S, Xu W, Wang Y, Li L, et al
The "LLQY" motif on SARS-CoV-2 spike protein affects S incorporation into virus particles.
J Virol. 2022 Jan 19:jvi0189721. doi: 10.1128/jvi.01897.
PubMed Abstract available

TANG B, Sun EZ, Zhang ZL, Liu SL, et al
Sphingomyelin-Sequestered Cholesterol Domain Recruits Formin-Binding Protein 17 for Constricting Clathrin-Coated Pits in Influenza Virus Entry.
J Virol. 2022 Jan 12:JVI0181321. doi: 10.1128/JVI.01813.
PubMed Abstract available

BHAT S, James J, Sadeyen JR, Mahmood S, et al
Co-infection of chickens with H9N2 and H7N9 avian influenza viruses leads to emergence of reassortant H9N9 virus with increased fitness for poultry and a zoonotic potential.
J Virol. 2022 Jan 12:jvi0185621. doi: 10.1128/jvi.01856.
PubMed Abstract available

VELER H, Fan H, Keown J, Sharps J, et al
The C-terminal domains of the PB2 subunit of the influenza A virus RNA polymerase directly interact with cellular GTPase Rab11a.
J Virol. 2022 Jan 12:jvi0197921. doi: 10.1128/jvi.01979.
PubMed Abstract available

RASHID MU, Gao A, Coombs KM
Influenza A virus uses PSMA2 for downregulation of NRF2-mediated oxidative stress response.
J Virol. 2022 Jan 12:jvi0199021. doi: 10.1128/jvi.01990.
PubMed Abstract available

Articles of Significant Interest in This Issue.
J Virol. 2022;96:e0186421.
PubMed

CHAUDHRY MZ, Eschke K, Hoffmann M, Grashoff M, et al
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
J Virol. 2022 Jan 12:jvi0218621. doi: 10.1128/jvi.02186.
PubMed Abstract available

KIMBLE JB, Wymore Brand M, Kaplan BS, Gauger P, et al
Vaccine-associated enhanced respiratory disease following influenza virus infection in ferrets recapitulates the model in pigs.
J Virol. 2022 Jan 5:JVI0172521. doi: 10.1128/JVI.01725.
PubMed Abstract available

December 2021

HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
PubMed Abstract available

NILSSON-PAYANT BE, tenOever BR, Te Velthuis AJW
The host factor ANP32A is required for influenza A virus vRNA and cRNA synthesis.
J Virol. 2021 Dec 22:jvi0209221. doi: 10.1128/jvi.02092.
PubMed Abstract available

OLIVARRIA GM, Cheng Y, Furman S, Pachow C, et al
Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
J Virol. 2021 Dec 22:jvi0196921. doi: 10.1128/jvi.01969.
PubMed Abstract available

ETTICH J, Werner J, Weitz HT, Mueller E, et al
A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
PubMed Abstract available

GUO J, Chen J, Li Y, Li Y, et al
SUMOylation of matrix protein M1 and filamentous morphology collectively contribute to the replication and virulence of highly pathogenic H5N1 avian influenza viruses in mammals.
J Virol. 2021 Dec 15:JVI0163021. doi: 10.1128/JVI.01630.
PubMed Abstract available

CAO K, Wang X, Peng H, Ding L, et al
A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
PubMed Abstract available

NELSON M, O'Brien LM, Davies C, Keyser E, et al
Comparison of experimental MERS-CoV infection acquired by three individual routes of infection in the common marmoset.
J Virol. 2021 Dec 15:JVI0173921. doi: 10.1128/JVI.01739.
PubMed Abstract available

SAKA N, Matsumoto Y, Ohta K, Kolakofsky D, et al
A point mutation in human parainfluenza virus type 2 nucleoprotein leads to two separate effects on virus replication.
J Virol. 2021 Dec 8:JVI0206721. doi: 10.1128/JVI.02067.
PubMed Abstract available

ZHANG Y, Yan Q, Luo K, He P, et al
Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection.
J Virol. 2021 Dec 8:JVI0160021. doi: 10.1128/JVI.01600.
PubMed Abstract available

MALICOAT J, Manivasagam S, Zuniga S, Sola I, et al
Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories.
J Virol. 2021 Dec 1:JVI0183721. doi: 10.1128/JVI.01837.
PubMed Abstract available

November 2021

ZHANG S, Go EP, Ding H, Anang S, et al
Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
J Virol. 2021 Nov 24:JVI0162621. doi: 10.1128/JVI.01626.
PubMed Abstract available

MARTINS M, Fernandes MHV, Joshi LR, Diel DG, et al
Age-related susceptibility of ferrets to SARS-CoV-2 infection.
J Virol. 2021 Nov 24:JVI0145521. doi: 10.1128/JVI.01455.
PubMed Abstract available

BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
PubMed Abstract available

TAKAMATSU Y, Imai M, Maeda K, Nakajima N, et al
Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
J Virol. 2021 Nov 24:JVI0155121. doi: 10.1128/JVI.01551.
PubMed Abstract available

ZHANG H, Zheng H, Guo P, Hu L, et al
Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
J Virol. 2021;95:e0175021.
PubMed

LIU Y, Wang B, Liang QZ, Shi FS, et al
Roles of Two Major Domains of the Porcine Deltacoronavirus S1 Subunit in Receptor Binding and Neutralization.
J Virol. 2021;95:e0111821.
PubMed Abstract available

DANIELS RS, Galiano M, Ermetal B, Kwong J, et al
Temporal and gene reassortment analysis of influenza C outbreaks in Hong Kong SAR, China.
J Virol. 2021 Nov 17:JVI0192821. doi: 10.1128/JVI.01928.
PubMed Abstract available

CHAI H, Li X, Li M, Lv X, et al
Emergence, Evolution, and Pathogenicity of Influenza A(H7N4) Virus in Shorebirds, China.
J Virol. 2021 Nov 17:JVI0171721. doi: 10.1128/JVI.01717.
PubMed Abstract available

SOUZA CK, Anderson TK, Chang J, Venkatesh D, et al
Antigenic distance between North American swine and human seasonal H3N2 influenza A viruses as an indication of zoonotic risk to humans.
J Virol. 2021 Nov 10:JVI0137421. doi: 10.1128/JVI.01374.
PubMed Abstract available

BASU A, Penumutchu S, Nguyen K, Mbonye U, et al
A structurally conserved RNA element within SARS-CoV-2 ORF1a RNA and S mRNA regulates translation in response to viral S protein-induced signaling in human lung cells.
J Virol. 2021 Nov 10:JVI0167821. doi: 10.1128/JVI.01678.
PubMed Abstract available

DONG X, Wang X, Xie M, Wu W, et al
Structural Basis of Human Parainfluenza Virus 3 Unassembled Nucleoprotein in Complex with Its Viral ChaperoneHPIV3 Nucleoprotein-Phosphoprotein Structure.
J Virol. 2021 Nov 3:JVI0164821. doi: 10.1128/JVI.01648.
PubMed Abstract available

LAMARCA AP, de Almeida LGP, da Silva Francisco Junior R, Cavalcante L, et al
Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil.
J Virol. 2021 Nov 3:JVI0122821. doi: 10.1128/JVI.01228.
PubMed Abstract available

October 2021

DESCAMPS D, Peres de Oliveira A, Gonnin L, Madrieres S, et al
Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
J Virol. 2021;95:e0091221.
PubMed Abstract available

YAN B, Chakravorty S, Mirabelli C, Wang L, et al
Reply to Grigoriev et al., "Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs 1 of Non-coding RNA?"
J Virol. 2021 Oct 27:JVI0169021. doi: 10.1128/JVI.01690.
PubMed Abstract available

YU J, Collins ND, Mercado NB, McMahan K, et al
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
PubMed Abstract available

GRIGORIEV A, Kelley JJ, Guan L
Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs of Non-coding RNA?
J Virol. 2021 Oct 27:JVI0146221. doi: 10.1128/JVI.01462.
PubMed Abstract available

TAN J, O'Dell G, Hernandez MM, Sordillo EM, et al
Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model.
J Virol. 2021 Oct 20:JVI0142121. doi: 10.1128/JVI.01421.
PubMed Abstract available

WINKLER ES, Chen RE, Alam F, Yildiz S, et al
SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice.
J Virol. 2021 Oct 20:JVI0151121. doi: 10.1128/JVI.01511.
PubMed Abstract available

DONG W, Mead H, Tian L, Park JG, et al
The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
J Virol. 2021 Oct 20:JVI0096421. doi: 10.1128/JVI.00964.
PubMed Abstract available

REN W, Zhu Y, Lan J, Chen H, et al
Susceptibilities of human ACE2 genetic variants in coronavirus infection.
J Virol. 2021 Oct 20:JVI0149221. doi: 10.1128/JVI.01492.
PubMed Abstract available

SIDDIQ MM, Chan AT, Miorin L, Yadaw AS, et al
Functional Effects of Cardiomyocyte Injury in COVID-19.
J Virol. 2021 Oct 20:JVI0106321. doi: 10.1128/JVI.01063.
PubMed Abstract available

GAO Q, Yang C, Ren C, Zhang S, et al
Correction for Gao et al., "Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus".
J Virol. 2021;95:e0141321.
PubMed

GAO J, Klenow L, Parsons L, Malik T, et al
Design of the Recombinant Influenza Neuraminidase Antigen is Crucial for its Biochemical Properties and Protective Efficacy.
J Virol. 2021 Oct 6:JVI0116021. doi: 10.1128/JVI.01160.
PubMed Abstract available

BESSIERE P, Figueroa T, Coggon A, Foret-Lucas C, et al
Opposite outcomes of the within-host competition between highly and low pathogenic H5N8 avian influenza viruses in chickens compared to ducks.
J Virol. 2021 Oct 6:JVI0136621. doi: 10.1128/JVI.01366.
PubMed Abstract available

NAVARATNARAJAH CK, Pease DR, Halfmann P, Taye B, et al
Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.
J Virol. 2021 Oct 6:JVI0136821. doi: 10.1128/JVI.01368.
PubMed Abstract available

September 2021

SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
PubMed Abstract available

SHUE B, Chiramel AI, Cerikan B, To TH, et al
Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication.
J Virol. 2021 Sep 29:JVI0059621. doi: 10.1128/JVI.00596.
PubMed Abstract available

KIM YJ, Witwit H, Cubitt B, de la Torre JC, et al
Inhibitors of anti-apoptotic Bcl-2 family proteins exhibit potent and broad-spectrum anti-mammarenavirus activity via cell cycle arrest at G0/G1 phase.
J Virol. 2021 Sep 29:JVI0139921. doi: 10.1128/JVI.01399.
PubMed Abstract available

TANG W, Li Y, Song Q, Wang Z, et al
Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.
J Virol. 2021;95:e0120521.
PubMed Abstract available

PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
PubMed Abstract available

QIAN Y, Lei T, Patel PS, Lee CH, et al
Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
PubMed Abstract available

CHOI A, Koch M, Wu K, Dixon G, et al
Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
PubMed Abstract available

ACHARYA A, Pandey K, Thurman M, Klug E, et al
Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants.
J Virol. 2021 Sep 22:JVI0143721. doi: 10.1128/JVI.01437.
PubMed Abstract available

SHANG C, Zhuang X, Zhang H, Li Y, et al
Inhibition of autophagy suppresses SARS-CoV-2 replication and ameliorates pneumonia in hACE2 transgenic mice and xenografted human lung tissues.
J Virol. 2021 Sep 22:JVI0153721. doi: 10.1128/JVI.01537.
PubMed Abstract available

KIRCHENBAUM GA, Sautto GA, Richardson RA, Ecker JW, et al
A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus.
J Virol. 2021 Sep 15:JVI0237920. doi: 10.1128/JVI.02379.
PubMed Abstract available

TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
PubMed Abstract available

NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
PubMed Abstract available

CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
PubMed Abstract available

ABRAHAM M, Beavis AC, Xiao P, Villinger FJ, et al
Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus (JPV)-expressing HA of influenza A virus H5N1.
J Virol. 2021 Sep 1:JVI0132121. doi: 10.1128/JVI.01321.
PubMed Abstract available

WILLIAMS CM, Roy S, Califano D, McKenzie ANJ, et al
IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine.
J Virol. 2021 Sep 1:JVI0059821. doi: 10.1128/JVI.00598.
PubMed Abstract available

August 2021

XUN G, Song X, Hu J, Zhang H, et al
Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
J Virol. 2021;95:e0048521.
PubMed Abstract available

SATO K, Hayashi H, Shimotai Y, Yamaya M, et al
TMPRSS2 activates hemagglutinin-esterase glycoprotein of influenza C virus.
J Virol. 2021 Aug 18:JVI0129621. doi: 10.1128/JVI.01296.
PubMed Abstract available

KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
PubMed Abstract available

KAPLAN BS, Anderson TK, Chang J, Santos J, et al
Evolution and antigenic advancement of N2 neuraminidase of swine influenza A viruses circulating in the United States following two separate introductions from human seasonal viruses.
J Virol. 2021 Aug 11:JVI0063221. doi: 10.1128/JVI.00632.
PubMed Abstract available

KAWAI A, Yamamoto Y, Nogimori T, Takeshita K, et al
The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses.
J Virol. 2021 Aug 11:JVI0118021. doi: 10.1128/JVI.01180.
PubMed Abstract available

TAM EH, Liu YC, Woung CH, Liu HM, et al
Role of the chaperone protein 14-3-3epsilon in the regulation of influenza A virus-activated beta interferon.
J Virol. 2021 Aug 11:JVI0023121. doi: 10.1128/JVI.00231.
PubMed Abstract available

LU M, Zhang Y, Dravid P, Li A, et al
A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
PubMed Abstract available

July 2021

DEL SARTO J, Gerlt V, Friedrich ME, Anhlan D, et al
Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection.
J Virol. 2021 Jul 28:JVI0067221. doi: 10.1128/JVI.00672.
PubMed Abstract available

BESTLE D, Limburg H, Kruhl D, Harbig A, et al
Hemagglutinins of avian influenza viruses are proteolytically activated by TMPRSS2 in human and murine airway cells.
J Virol. 2021 Jul 28:JVI0090621. doi: 10.1128/JVI.00906.
PubMed Abstract available

CANTWELL AM, Singh H, Platt M, Yu Y, et al
Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
PubMed Abstract available

RAHMAN K, Compton AA
The indirect antiviral potential of long non-coding RNAs encoded by IFITM pseudogenes.
J Virol. 2021 Jul 28:JVI0068021. doi: 10.1128/JVI.00680.
PubMed Abstract available

GREEN G, Johnson SM, Costello H, Brakel K, et al
CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
J Virol. 2021;95:e0001021.
PubMed Abstract available

YANG J, Zhang P, Huang M, Qiao S, et al
Key amino acids of M1-41 and M2-27 determine growth and pathogenicity of chimeric H17 bat influenza virus in cells and in mice.
J Virol. 2021 Jul 21:JVI0101921. doi: 10.1128/JVI.01019.
PubMed Abstract available

LI Z, Gao F, Lan Y, Guan J, et al
Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
PubMed Abstract available

FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
PubMed Abstract available

CHEN DY, Khan N, Close BJ, Goel RK, et al
SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
PubMed Abstract available

LAI KK, Cheung NN, Yang F, Dai J, et al
Correction for Lai et al., "Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics".
J Virol. 2021;95:e0066521.
PubMed

LIANG W, Zhang Y, Li M, Al-Shaebi F, et al
Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.
J Virol. 2021;95:e0056321.
PubMed Abstract available

LEYSON CM, Youk S, Ferreira HL, Suarez DL, et al
Multiple gene segments are associated with enhanced virulence of clade 2.3.4.4 H5N8 highly pathogenic avian influenza virus in mallards.
J Virol. 2021 Jul 7:JVI0095521. doi: 10.1128/JVI.00955.
PubMed Abstract available

June 2021

YU J, Huang C, Sheng Z, Wang Z, et al
Identification of One Critical Amino Acid Residue of the Nucleoprotein as a Determinant for in vitro Viral Replication Fitness of Influenza D Virus.
J Virol. 2021 Jun 30:JVI0097121. doi: 10.1128/JVI.00971.
PubMed Abstract available

XIAO Y, Zhang W, Pan M, Bauer DLV, et al
A synergistic effect between 3' terminal noncoding and adjacent coding regions of influenza A virus HA segment on template preference.
J Virol. 2021 Jun 30:JVI0087821. doi: 10.1128/JVI.00878.
PubMed Abstract available

NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
PubMed Abstract available

BLAUROCK C, Breithaupt A, Scheibner D, Bagato O, et al
Preferential selection and contribution of non-structural protein 1 (NS1) to the efficient transmission of the panzootic avian influenza H5N8 2.3.4.4 clades A and B viruses in chickens and ducks.
J Virol. 2021 Jun 23:JVI0044521. doi: 10.1128/JVI.00445.
PubMed Abstract available

SKARLUPKA AL, Bebin-Blackwell AG, Sumner SF, Ross TM, et al
Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains.
J Virol. 2021 Jun 23:JVI0075921. doi: 10.1128/JVI.00759.
PubMed Abstract available

SUN G, Sui Y, Zhou Y, Ya J, et al
Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
PubMed Abstract available

KUMAR A, Ishida R, Strilets T, Cole J, et al
SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
J Virol. 2021;95:e0026621.
PubMed Abstract available

WANG X, Zhao Y, Yan F, Wang T, et al
Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
PubMed Abstract available

NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
PubMed Abstract available

OU J, Zhou Z, Dai R, Zhang J, et al
V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
PubMed Abstract available

May 2021

LIU H, Plancarte M, Ball EE, Weiss CM, et al
Respiratory tract explant infection dynamics of influenza A virus in California sea lions, northern elephant seals, and rhesus macaques.
J Virol. 2021 May 26:JVI0040321. doi: 10.1128/JVI.00403.
PubMed Abstract available

BAKRE A, Jones L, Murray J, Reneer ZB, et al
Innate antiviral cytokine response to swine influenza virus by swine respiratory epithelial cells.
J Virol. 2021 May 12. pii: JVI.00692-21. doi: 10.1128/JVI.00692.
PubMed Abstract available

YAN B, Chakravorty S, Mirabelli C, Wang L, et al
Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
PubMed Abstract available

LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
PubMed Abstract available

TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
PubMed Abstract available

LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
PubMed Abstract available

HORMAN WSJ, Kedzierska K, Rootes CL, Bean AGD, et al
Upregulated expression of ferret Interferon-Inducible Transmembrane genes by IFN-alpha and influenza virus infection.
J Virol. 2021 May 5. pii: JVI.00111-21. doi: 10.1128/JVI.00111.
PubMed Abstract available

April 2021

RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
PubMed Abstract available

ALFI O, Yakirevitch A, Wald O, Wandel O, et al
Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
PubMed Abstract available

VIDAL SJ, Collier AY, Yu J, McMahan K, et al
Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
PubMed Abstract available

SAUTTO GA, Ecker JW, Ross TM
An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus.
J Virol. 2021 Apr 14. pii: JVI.02421-20. doi: 10.1128/JVI.02421.
PubMed Abstract available

CHIEM K, Lopez-Garcia D, Ortego J, Martinez-Sobrido L, et al
Identification of amino acid residues required for inhibition of host gene expression by influenza A/Viet Nam/1203/2004 H5N1 PA-X.
J Virol. 2021 Apr 14. pii: JVI.00408-21. doi: 10.1128/JVI.00408.
PubMed Abstract available

NILSSON-PAYANT BE, Blanco-Melo D, Uhl S, Escudero-Perez B, et al
Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
J Virol. 2021;95.
PubMed Abstract available

MORI K, Ohniwa RL, Takizawa N, Naito T, et al
Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
PubMed Abstract available

ZHENG J, Wen L, Yen HL, Liu M, et al
Phenotypic and functional characteristics of a novel influenza hemagglutinin-specific memory NK cell.
J Virol. 2021 Apr 7. pii: JVI.00165-21. doi: 10.1128/JVI.00165.
PubMed Abstract available

ZHANG H, Zheng H, Guo P, Hu L, et al
Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine.
J Virol. 2021 Apr 7. pii: JVI.00507-21. doi: 10.1128/JVI.00507.
PubMed Abstract available

PATEL DR, Field CJ, Septer KM, Sim DG, et al
Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
PubMed Abstract available

March 2021

WANG J, Shu T, Deng W, Zheng Y, et al
Mucosal priming with a recombinant influenza A virus-vectored vaccine elicits T-cell and antibody responses to HIV-1 in mice.
J Virol. 2021 Mar 31. pii: JVI.00059-21. doi: 10.1128/JVI.00059.
PubMed Abstract available

LIU W, Reyes HM, Yang JF, Li Y, et al
Activation of STING signaling pathway effectively blocks human coronavirus infection.
J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
PubMed Abstract available

TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
PubMed Abstract available

SLAINE PD, Kleer M, Duguay BA, Pringle ES, et al
Thiopurines activate an antiviral unfolded protein response that blocks influenza A virus glycoprotein accumulation.
J Virol. 2021 Mar 24. pii: JVI.00453-21. doi: 10.1128/JVI.00453.
PubMed Abstract available

DANZY S, Lowen AC, Steel J
A quantitative approach to assess influenza A virus fitness and transmission in guinea pigs.
J Virol. 2021 Mar 17. pii: JVI.02320-20. doi: 10.1128/JVI.02320.
PubMed Abstract available

PU J, Yin Y, Liu J, Wang X, et al
Reassortment with dominant chicken H9N2 influenza virus contributed to the fifth H7N9 virus human epidemic.
J Virol. 2021 Mar 17. pii: JVI.01578-20. doi: 10.1128/JVI.01578.
PubMed Abstract available

YANG H, Winkler W, Wu X
Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1.
J Virol. 2021 Mar 10. pii: JVI.00283-21. doi: 10.1128/JVI.00283.
PubMed Abstract available

PENG J, Ran Y, Xie H, Deng L, et al
Sarco/Endoplasmic Reticulum Ca(2+) Transporting ATPase (SERCA) Modulates Autophagic, Inflammatory, and Mitochondrial Responses during Influenza A Virus Infection in Human Lung Cells.
J Virol. 2021 Mar 10. pii: JVI.00217-21. doi: 10.1128/JVI.00217.
PubMed Abstract available

GONG W, He X, Huang K, Zhang Y, et al
Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly.
J Virol. 2021 Mar 3. pii: JVI.00008-21. doi: 10.1128/JVI.00008.
PubMed Abstract available

PHAN T, Fay EJ, Lee Z, Aron S, et al
Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.
J Virol. 2021 Mar 3. pii: JVI.02102-20. doi: 10.1128/JVI.02102.
PubMed Abstract available

LUO Z, Girton AW, Heaton BE, Heaton NS, et al
Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.
J Virol. 2021 Mar 3. pii: JVI.02021-20. doi: 10.1128/JVI.02021.
PubMed Abstract available

February 2021

JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
Correction for Jeong et al., "In Vitro Profiling of Laninamivir-Resistant Substitutions in N3 to N9 Avian Influenza Virus Neuraminidase Subtypes and Their Association with In Vivo Susceptibility".
J Virol. 2021;95.
PubMed

YANG F, Pang B, Lai KK, Cheung NN, et al
Discovery of a novel specific inhibitor targeting influenza A nucleoprotein with pleiotropic inhibitory effects on various steps of viral life cycle.
J Virol. 2021 Feb 24. pii: JVI.01432-20. doi: 10.1128/JVI.01432.
PubMed Abstract available

DHAKAL S, Loube J, Misplon JA, Lo CY, et al
Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
PubMed Abstract available

HOYE BJ, Donato CM, Lisovski S, Deng YM, et al
Reassortment and persistence of influenza A viruses from diverse geographic origins within Australian wild birds: evidence from a small, isolated population of Ruddy turnstones.
J Virol. 2021 Feb 24. pii: JVI.02193-20. doi: 10.1128/JVI.02193.
PubMed Abstract available

BINJAWADAGI B, Ma Y, Binjawadagi R, Brakel K, et al
Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
J Virol. 2021;95.
PubMed Abstract available

HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
PubMed Abstract available

ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
GPCR and ion channel genes used by influenza virus for replication.
J Virol. 2021 Feb 3. pii: JVI.02410-20. doi: 10.1128/JVI.02410.
PubMed Abstract available

January 2021

LEVENE RE, Shrestha SD, Gaglia MM
The influenza A virus host shutoff factor PA-X is rapidly turned over in a strain-specific manner.
J Virol. 2021 Jan 27. pii: JVI.02312-20. doi: 10.1128/JVI.02312.
PubMed Abstract available

ZHANG X, Pu J, Sun Y, Yuhai B, et al
Neurovirulence of avian influenza virus is dependent on the interaction of viral NP protein with host factor FMRP in the murine brain.
J Virol. 2021 Jan 6. pii: JVI.01272-20. doi: 10.1128/JVI.01272.
PubMed Abstract available

PATIL A, Anhlan D, Ferrando V, Mecate-Zambrano A, et al
Phosphorylation of influenza A virus NS1 at serine 205 mediates its viral polymerase-enhancing function.
J Virol. 2021 Jan 6. pii: JVI.02369-20. doi: 10.1128/JVI.02369.
PubMed Abstract available

FENG M, Zhang Q, Wu W, Chen L, et al
Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-kappaB and JAK-STAT Signaling Pathways.
J Virol. 2021 Jan 6. pii: JVI.02038-20. doi: 10.1128/JVI.02038.
PubMed Abstract available

OHTA K, Saka N, Nishio M
Human parainfluenza virus type 2 V protein modulates iron homeostasis.
J Virol. 2021 Jan 6. pii: JVI.01861-20. doi: 10.1128/JVI.01861.
PubMed Abstract available

December 2020

WANG Q, Pan W, Wang S, Pan C, et al
Protein tyrosine phosphatase SHP2 suppresses host innate immunity against influenza A virus through regulating EGFR-mediated signaling.
J Virol. 2020 Dec 23. pii: JVI.02001-20. doi: 10.1128/JVI.02001.
PubMed Abstract available

VERHAGEN JH, Eriksson P, Leijten L, Blixt O, et al
Host range of influenza A virus H1 to H16 in Eurasian ducks based on tissue and receptor binding studies.
J Virol. 2020 Dec 23. pii: JVI.01873-20. doi: 10.1128/JVI.01873.
PubMed Abstract available

HUMAN S, Hotard AL, Rostad CA, Lee S, et al
A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
J Virol. 2020;95.
PubMed Abstract available

LEE E, Sandgren K, Duette G, Stylianou VV, et al
Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
PubMed Abstract available

YOUK SS, Leyson CM, Seibert BA, Jadhao S, et al
Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade 2.3.4.4 in Chickens.
J Virol. 2020 Dec 2. pii: JVI.01675-20. doi: 10.1128/JVI.01675.
PubMed Abstract available

BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
J Virol. 2020 Dec 2. pii: JVI.01027-20. doi: 10.1128/JVI.01027.
PubMed Abstract available

EVERETT HE, van Diemen PM, Aramouni M, Ramsay A, et al
Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs.
J Virol. 2020 Dec 2. pii: JVI.01787-20. doi: 10.1128/JVI.01787.
PubMed Abstract available

PEACOCK TP, Sealy JE, Harvey WT, Benton DJ, et al
Genetic determinants of receptor-binding preference and zoonotic potential of H9N2 avian influenza viruses.
J Virol. 2020 Dec 2. pii: JVI.01651-20. doi: 10.1128/JVI.01651.
PubMed Abstract available

November 2020

PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
PubMed Abstract available

CLARK LK, Green TJ, Petit CM
Structure of nonstructural protein 1 from SARS-CoV-2.
J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
PubMed Abstract available

MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
PubMed Abstract available

MA N, Li X, Jiang H, Dai Y, et al
Influenza neuraminidase engages CD83 and promotes pulmonary injury.
J Virol. 2020 Nov 11. pii: JVI.01753-20. doi: 10.1128/JVI.01753.
PubMed Abstract available

BAO D, Xue R, Zhang M, Lu C, et al
N-linked glycosylation plays an important role in budding of NA protein and virulence of influenza viruses.
J Virol. 2020 Nov 11. pii: JVI.02042-20. doi: 10.1128/JVI.02042.
PubMed Abstract available

TIAN X, Landreth S, Lu Y, Pandey K, et al
A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
J Virol. 2020 Nov 11. pii: JVI.02154-20. doi: 10.1128/JVI.02154.
PubMed Abstract available

JENKINS T, Wang R, Harder O, Xue M, et al
A novel live attenuated RSV vaccine candidate with mutations in the L protein SAM binding site and the G protein cleavage site is protective in cotton rats and a rhesus macaque.
J Virol. 2020 Nov 11. pii: JVI.01568-20. doi: 10.1128/JVI.01568.
PubMed Abstract available

FENWICK C, Croxatto A, Coste AT, Pojer F, et al
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
PubMed Abstract available

October 2020

DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
PubMed Abstract available

LIANG B, Matsuoka Y, Le Nouen C, Liu X, et al
A parainfluenza virus vector expressing the respiratory syncytial virus (RSV) prefusion F protein is more effective than RSV for boosting a primary immunization with RSV.
J Virol. 2020 Oct 28. pii: JVI.01512-20. doi: 10.1128/JVI.01512.
PubMed Abstract available

GHORBANI A, Abundo MC, Ji H, Taylor KJM, et al
Viral Subpopulation Screening Guides in Designing a High Interferon Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
J Virol. 2020 Oct 28. pii: JVI.01722-20. doi: 10.1128/JVI.01722.
PubMed Abstract available

COOK PW, Stark T, Jones J, Kondor R, et al
Detection and Characterization of Swine-origin Influenza A(H1N1) Pandemic 2009 Viruses in Humans Following Zoonotic Transmission.
J Virol. 2020 Oct 28. pii: JVI.01066-20. doi: 10.1128/JVI.01066.
PubMed Abstract available

RENEER ZB, Jamieson PJ, Skarlupka AL, Huang Y, et al
Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
J Virol. 2020 Oct 28. pii: JVI.01526-20. doi: 10.1128/JVI.01526.
PubMed Abstract available

JOBE F, Simpson J, Hawes P, Guzman E, et al
Respiratory Syncytial Virus Sequesters NF-kappaB Subunit p65 to Cytoplasmic Inclusion Bodies To Inhibit Innate Immune Signaling.
J Virol. 2020;94.
PubMed Abstract available

GAO Q, Yang C, Ren C, Zhang S, et al
Eukaryotic translation elongation factor 1 delta inhibits the nuclear import of nucleoprotein and PA-PB1 heterodimer of influenza A virus.
J Virol. 2020 Oct 21. pii: JVI.01391-20. doi: 10.1128/JVI.01391.
PubMed Abstract available

MANZOOR R, Eguchi N, Yoshida R, Ozaki H, et al
A novel mechanism underlying antiviral activity of an influenza virus M2-specific antibody.
J Virol. 2020 Oct 14. pii: JVI.01277-20. doi: 10.1128/JVI.01277.
PubMed Abstract available

JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
In vitro profiling of laninamivir-resistant substitutions in N3 to N9 avian influenza neuraminidase subtypes and their association with in vivo susceptibility.
J Virol. 2020 Oct 14. pii: JVI.01679-20. doi: 10.1128/JVI.01679.
PubMed Abstract available

MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
PubMed Abstract available

LI Z, Qu X, Liu X, Huan C, et al
GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
J Virol. 2020;94.
PubMed Abstract available

ARAI Y, Kawashita N, Elgendy EM, Ibrahim MS, et al
PA mutations inherited during viral evolution act cooperatively to increase replication of contemporary H5N1 influenza virus with an expanded host range.
J Virol. 2020 Oct 7. pii: JVI.01582-20. doi: 10.1128/JVI.01582.
PubMed Abstract available

WEI Y, Zeng Y, Zhang X, Xu S, et al
The Nucleoprotein of H7N9 Influenza Virus Positively Regulates TRAF3-Mediated Innate Signaling and Attenuates Viral Virulence in Mice.
J Virol. 2020 Oct 7. pii: JVI.01640-20. doi: 10.1128/JVI.01640.
PubMed Abstract available

September 2020

CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
PubMed Abstract available

NELSON MI, Perofsky A, McBride DS, Rambo-Martin BL, et al
A heterogenous swine show circuit drives zoonotic transmission of influenza A viruses in the United States.
J Virol. 2020 Sep 30. pii: JVI.01453-20. doi: 10.1128/JVI.01453.
PubMed Abstract available

XUE M, Wang R, Harder O, Chen P, et al
Stable attenuation of human respiratory syncytial virus for live vaccines by deletion and insertion of amino acids in the hinge region between the mRNA capping and methyltransferase domains of the large polymerase protein.
J Virol. 2020 Sep 30. pii: JVI.01831-20. doi: 10.1128/JVI.01831.
PubMed Abstract available

KINDER JT, Moncman CL, Barrett C, Jin H, et al
Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
J Virol. 2020;94.
PubMed Abstract available

BROCATO RL, Principe LM, Kim RK, Zeng X, et al
Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
PubMed Abstract available

August 2020

BUSSE DC, Habgood-Coote D, Clare S, Brandt C, et al
Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus.
J Virol. 2020;94.
PubMed Abstract available

FROGGATT HM, Heaton BE, Heaton NS
Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
PubMed Abstract available

WESTON S, Coleman CM, Haupt R, Logue J, et al
Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
PubMed Abstract available

JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
PubMed Abstract available

July 2020

KAPLAN BS, Kimble JB, Chang J, Anderson TK, et al
Aerosol Transmission from Infected Swine to Ferrets of an H3N2 Virus Collected from an Agricultural Fair and Associated with Human Variant Infections.
J Virol. 2020;94.
PubMed Abstract available

VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
PubMed Abstract available

June 2020

GHAFARI M, Lumby CK, Weissman DB, Illingworth CJR, et al
Inferring Transmission Bottleneck Size from Viral Sequence Data Using a Novel Haplotype Reconstruction Method.
J Virol. 2020;94.
PubMed Abstract available

DENG Y, Herbert JA, Robinson E, Ren L, et al
Neutrophil-Airway Epithelial Interactions Result in Increased Epithelial Damage and Viral Clearance during Respiratory Syncytial Virus Infection.
J Virol. 2020;94.
PubMed Abstract available

May 2020

LI J, Li M, Wang X, Sun M, et al
Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
J Virol. 2020;94.
PubMed Abstract available

April 2020

YANG J, Ma C, Zhao Y, Fan A, et al
Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology.
J Virol. 2020 Apr 22. pii: JVI.00007-20. doi: 10.1128/JVI.00007.
PubMed Abstract available

KANDASAMY M, Furlong K, Perez JT, Manicassamy S, et al
Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
J Virol. 2020;94.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: